The use of the morantel sustained release bolus under special farm practices (deprime system) in France

The efficacy of the morantel sustained release bolus in controlling gastrointestinal and lungworm parasites when used in first-season grazing animals which followed older animals onto spring pasture (deprime system) was assessed in three trials conducted in Normandy, France. In each trial first-season grazing calves were equally allocated onto two separate but equivalent paddocks where they remained throughout the grazing season. A morantel sustained release bolus was administered to one group of animals at turnout, the other group remained as controls. The effect of the treatment on contamination of pasture (herbage larval counts and tracer worm counts), on faecal worm egg and lungworm larval counts, and on weight gain performance of the principal animals was assessed. In all three trials, worm egg output in the bolus-treated animals was substantially lower throughout the season compared with the control animals. Worm burdens of tracer calves grazing pastures of the treated cattle were also reduced compared with tracer calves grazing control pastures. Clinical parasitic gastroenteritis occurred in the control animals but not in the bolus-treated animals in one trial. Overall the bolus-treated animals outperformed the controls by a mean weight gain advantage of 10.5 kg (P less than 0.01).     

Grazing study in Ireland using the morantel sustained release bolus for controlling nematodiasis in calves

The morantel sustained release bolus was administered at turnout to first-season grazing calves in order to assess its efficacy in the seasonal control of infection by nematode parasites in Ireland. The pastures grazed by control calves showed a marked increase in gastrointestinal trichostrongylid infective larvae by September, while numbers of infective larvae on pasture grazed by bolus-treated calves remained at a low level throughout the grazing season. In consequence, the controls showed significantly higher worm egg counts in late season and significantly higher worm burdens (mainly Ostertagia spp) at necropsy carried out in November on representative number of principal animals selected from each group. These reduced worm burdens were attributed to the suppression of egg output during the early part of the season as a result of treatment with the morantel sustained release bolus at turnout in the spring. Pasture contamination with Dictyocaulus viviparus larvae was present on all treatment pastures. The bolus-treated calves however were subjected to an increase in D. viviparus infection which occurred on their pasture in late season after the active life of the bolus had expired. It was concluded that bolus treatment delayed (rather than prevented) the buildup of D. viviparus infection on the pasture by 60-90 days.     

Comparison of a levamisole sustained-release bolus and ivermectin treatment to prevent bovine lungworm infection

The efficacy of a levamisole sustained-release bolus to prevent parasitic bronchitis in calves in their first grazing season was compared to ivermectin treatment at three, eight and thirteen weeks after turn out. Contamination of the pasture was established by experimentally infected seeder calves. Twenty calves were split into two groups. Ten calves of one group received a bolus at the start of the experiment. In the other group the calves were treated with ivermectin at 21, 56 and 91 days. Two principal calves from each group were killed during the experiment to study histopathological changes. Pairs of tracer calves were introduced on both pastures at intervals of four weeks throughout the grazing period. The permanent calves were challenged with lungworm larvae at housing and slaughtered four weeks later. Both systems prevented parasitic bronchitis. Larval output was completely reduced in the ivermectin-treated calves while all bolus-treated calves excreted larvae at certain times. The highest group average was 4 larvae per gram faeces. Eosinophilia, ELISA-titres and histopathological changes confirmed the differences in larval uptake. Challenge infection was not successful in either group and no worms were found at slaughter. Weight gain was significantly different at housing in favour of the ivermectin-treated calves, but after challenge this was reduced due to a higher weight gain in the bolus-treated calves. The practical consequences of the results have been discussed.     

Effects of the fenbendazole SR bolus on Trichostrongylus infections in young calves during two consecutive grazing periods

A two-year study was conducted in northern Germany to investigate the effects of the fenbendazole slow release (SR) bolus on trichostrongyle infections in cattle. Two groups of dairy replacement calves were either given a bolus at their first turncut on pasture or treated with fenbendazole suspension twice in mid-summer and at housing. Bolus-treated and control animals were set stocked on separate pastures during their first grazing season (26 weeks) and grazed together during the second year (24 weeks). During the first season the bolus prevented substantially the output of strongyle eggs for more than four months resulting in a lower infection risk in late summer and autumn as compared to the control group. The plasma pepsinogen concentrations remained low in the bolus-treated cattle during their first grazing period but rose in the controls soon after turnout which indicated increasing trichostrongyle-caused damages of the abomasal mucosa. During the following housing period and the second grazing season the bolus-treated animals showed higher egg counts than the controls. No clinical sign of parasitic gastroenteritis and no patent lungworm infections were observed during the study. The bolus-treated cattle performed better than the control animals during both grazing seasons although the control group had compensated temporarily the group difference in weight gains during the housing period. In conclusion, the use of the fenbendazole SR bolus may impair the development of immunity to trichostrongyle infections to some extent but, under the present conditions, this does not seem of clinical or economic importance.     

Some observations on the use of the morantel sustained-release bolus in first season-grazing calves on a Belgian dairy cattle farm

The efficacy of the morantel sustained-release bolus (MSRB) in controlling gastrointestinal parasites in first-season grazing calves was evaluated on a dairy cattle farm in Belgium. The calves grazed a pasture which had been used by bolus-treated animals in the three previous years. The effect of bolus administration was determined with respect to live weight gain, faecal egg shedding, herbage larval counts, serum pepsinogen levels and ELISA antibody titres. In spite of an incomplete reduction of faecal egg shedding during the first months of the grazing season, bolus administration resulted in the prevention of parasitic gastro-enteritis in the calves. A weight gain advantage of 35,2 kg of the bolus-treated animals over the controls was noted already at two months after turnout. This weight gain advantage was maintained until housing. The usefulness of serum pepsinogen values and ELISA antibody titres as parameters in prevention experiments is stressed. Both serological parameters gave more information concerning infection level than did the faecal egg output and the herbage larval counts.     

A comparison of the efficacy of four different long-acting boluses to prevent infections with Dictyocaulus viviparus in calves

A field study of calves in their first grazing season tested the efficacy of four long-acting devices--a morantel sustained-release bolus, a levamisole sustained-release bolus, an oxfendazole interval bolus, and an albendazole interval bolus--against Dictyocaulus viviparus. The pasture had been previously contaminated by four calves orally inoculated with infective lungworm larvae. The calves were grazed together with four bolus-treated groups, each comprising four calves. Lungworm infection became patent in the experimentally inoculated calves between 22 and 26 days. Infection in the bolus-treated groups became patent after 54 days. The morantel bolus group excreted the most larvae, followed by the albendazole bolus group, and the levamisole bolus group. The oxfendazole bolus group excreted by far the least larvae. Eosinophil curves and ELISA titres showed that treated groups had essentially the same course of infection. The heavy infection to which the treated calves were exposed produced complete immunity in all groups. Challenge infection of 10,000 larvae at housing did not change any of the test parameters. Post-mortem examination showed only one positive calf with few worms. We concluded that when pastures are heavily infested with lungworm larvae, all boluses prevent severe clinical signs and allow build up of solid immunity, although none completely prevent excretion of larvae.     

Field evaluation of an experimental albendazole pulse release bolus in the control of parasitic gastroenteritis in first-season grazing calves

A field experiment is described which evaluates the use of an experimental albendazole pulse release bolus (E-bolus) on gastrointestinal parasitism. The bolus was administered at turnout to 9 first-season grazing calves and 9 animals were kept as controls on a separate pasture. Dry summer observed. The E-bolus introduced at the start of the grazing season provided moderate control of gastrointestinal parasitism. The beneficial effect of the treatment was demonstrated by lower strongyle egg counts and significant differences in ELISA extinctions for Ostertagia, Cooperia and Dictyocaulus. However pepsinogen values were elevated in the bolus-treated group, probably because of the long interval (31 days) between the pulsed treatments. Although not significant there was a trend for the bolus-treated group to gain more weight than the controls.     

Control of gastrointestinal strongylids in first year calves: use of Paratect Flex bolus at late pasture turnout]

The efficacy of the Paratect Flex-Bolus for the control of parasitic gastroenteritis in calves was evaluated in a field experiment in the Swiss midland region. The bolus was administered to 9 first year grazing calves at 4 to 5 months of age before turnout on June 26 while 9 calves remained as untreated controls. Both groups were rotated between 8 paddocks that had been pregrazed by older cattle in spring. For a period of 12 weeks the faecal egg output of the treated calves was reduced significantly (p < 0.05) compared to the controls, whereas no significant differences were observed in the mean serum pepsinogen values of both groups. At the end of the experiment (November 14) the bolus-treated calves showed a 4 kg weight gain advantage over the controls which was not significant. The mild infection levels in both groups were probably due to the low pasture contamination with infective larvae throughout the season which most likely resulted from the late turnout of the calves. An outbreak of dictyocaulosis was observed in both groups in October and confirmed that the Paratect Flex-Bolus provides insufficient protection against this infection.     

Use of an albendazole bolus against gastrointestinal nematode infections in first year cattle

Thirty first year grazing calves were allocated to two groups of 15 calves each on the basis of bodyweight and were administered albendazole boli or placebo boli, respectively, 30 days after turnout. The albendazole bolus prevented the nematode egg output almost completely for about 4 months, whereas the controls had mean egg counts of up to 206. Pepsinogen concentrations were significantly higher in the control group and reached mean values of 3055 mU tyrosine compared to less than 1000 mU tyrosine in the albendazole treated group after bolus administration. Pasture contamination with trichostrongylid larvae was markedly lower on pastures of the albendazole group than on the controls. Mean weight gains were significantly higher in the albendazole group than in the controls with a difference of 10.7 kg per animal at the end of the season.     

Efficacy of the morantel sustained-release bolus in grazing cattle in North America

The efficacy of using a bolus containing morantel in a sustained-release preparation for controlling naturally acquired gastrointestinal parasitic infections in weaned calves and yearling cattle was investigated during the 1982 grazing season at selected sites in the United States and Canada. According to a common trial design under various climatic and management conditions, 10 field trials were conducted with the bolus. At the time of spring turnout, a bolus was administered to each calf or yearling in the treated group. Then, treated and control cattle grazed separate but equal areas of divided pasture(s). The epidemiologic pattern of parasitic gastroenteritis in control animals and the effect of treatment on this pattern was determined in each trial. Safety and practicality of use of the bolus also were established. When compared with untreated cattle (control), those given the bolus deposited significantly (P less than 0.05) fewer worm eggs (89% reduction) during the first 90 days of the grazing season, as well as significantly fewer (P less than 0.05) worm eggs (84% reduction) during the entire grazing season. Consequently, during the second half of the grazing season, larval populations on treated pastures remained significantly (P less than 0.05) lower (66% reduction), compared with numbers of larvae found on control pastures. For pastures grazed by treated and control cattle at trial initiation, mean worm counts recovered from tracer calves were equal, indicating comparable pasture contamination at the beginning of the grazing season.(ABSTRACT TRUNCATED AT 250 WORDS)     

Use of an oxfendazole pulse release bolus in the control of parasitic gastroenteritis and parasitic bronchitis in first-season grazing calves

The efficacy of the oxfendazole pulse release bolus system for the control of parasitic gastroenteritis and parasitic bronchitis in first-season grazing calves was evaluated in Belgium. Twenty-two calves were allocated to two groups. The calves in one group received a bolus at the time of turn out, while the other group remained untreated. The efficacy of the bolus was assessed by comparison of faecal worm egg counts, plasma pepsinogen concentrations, the antibody response to Ostertagia, Cooperia and Dictyocaulus species total plasma protein and albumin concentrations, and weight gains throughout the grazing season and the housing period. The oxfendazole pulse release bolus provided good control of parasitic gastroenteritis dominated by ostertagia. The effects of parasitic gastritis were greatly reduced as shown by the significantly lower values of serum pepsinogen and ostertagia antibody titres. The use of the bolus further reduced the adverse effects of parasitism as indicated by better liveweight gains and normal total plasma protein and albumin concentrations whereas in the untreated control group hypoproteinaemia and hypoalbuminaemia were observed. Most animals exhibited clinical signs of parasitic bronchitis at the end of the grazing season, and the bolus may not adequately control parasitic bronchitis in all cases at all times.     

Epidemiology of trichostrongylidosis in cattle: development of infective larvae in the second part of the grazing period and their contribution to infections in the same year.

A grazing experiment was performed in the Swiss midland region with 22 first-season calves which were grazed together from May to mid July when they were allocated to two equal groups, one receiving a morantel sustained-release trilaminate bolus (Paratect Flex) bolus, Pfizer, Zurich, Switzerland) and the other one remaining as an untreated control. Each group was moved to a clean pasture on 21 July. The larval contamination on the pasture with the control animals reached 4652 third stage larvae (L3) per kilogram of dry matter (L3 kg-1 DM) after 10 weeks. Parasitic gastroenteritis was observed in two calves of the control group in August, and mean serum pepsinogen levels exceeded 4000 mU tyrosine in this group in September. Eggs from Ostertagia sp. and Cooperia sp. that were excreted by the animals at the beginning of July and the end of August showed similar hatching rates of 94% and 99%, respectively. In the calves of the bolus group the egg output was reduced by 95% within 14 days of administration of the bolus. Larval contamination on the pasture of the bolus group was zero until the beginning of September when a slight increase occurred, reaching 793 L3 kg-1 DM in October. At the end of the trial the bolus-treated calves had a mean weight gain advantage of 18 kg (P < 0.05) compared with the controls. The results confirm that a second generation of larvae developed on pasture in August and September and caused parasitic gastroenteritis in first-year grazing calves in late summer. The relevance of the results for the prophylaxis of parasitic gastroenteritis in calves in mixed grazing systems with calves and older cattle is discussed.     

Evaluation of the morantel sustained release trilaminate in the control of parasitic gastroenteritis in first season grazing cattle

A novel intraruminal bolus developed for the sustained delivery of the anthelmintic morantel tartrate was evaluated in the seasonal control of parasitic gastroenteritis in first season grazing calves. The morantel sustained release trilaminate is a trilaminate sheet consisting of a central lamina of a morantel tartrate/ethylene vinyl acetate matrix coated on both sides with a thin impermeable layer of ethylene vinyl acetate. A symmetrical pattern of circular perforations punched through the device controls the release of morantel. Administration of the trilaminate to calves significantly reduced their faecal egg output compared with untreated controls and thus reduced pasture larval contamination. Clinical parasitic gastroenteritis was prevented in the treated calves and there were significant reductions in their worm burdens compared with the untreated control calves both during and at the end of the grazing season. The control of parasitic gastroenteritis resulted in a significantly greater (P less than 0.0001) weight gain, of 45 kg, by the treated calves.     

Efficacy of a morantel sustained-release bolus for the control of gastrointestinal nematodes in Florida dairy heifers

The effectiveness of a morantel sustained-release bolus (MSRB) in controlling gastrointestinal nematode infections was determined in 70 Holstein heifer calves with no prior grazing experience. Calves were allotted to 2 treatment groups and were maintained in Florida during the grazing season on divided pastures of equal area. One MSRB was administered to each calf in 1 group at the time of turnout onto spring pasture, whereas calves in the other group remained as nonmedicated controls. By the end of the grazing season, treatment resulted in significantly (P less than 0.05) lower worm burdens and significantly improved weight gains. The MSRB-treated calves were able to reach breeding weight 2 to 4 weeks earlier than did nonmedicated calves.     

Efficacy of morantel against nematode populations in calves exposed on a pasture stocked for two years with morantel sustained-release bolus-treated calves

Two groups of 10 parasite-free calves were maintained either for 2 weeks on a pasture grazed by nonmedicated cattle (pasture A) or for 3 weeks on a pasture grazed by morantel sustained-release bolus-treated cattle (pasture B) for the preceding 2 years. After a 4-week holding period to allow for maturation of acquired gastrointestinal nematodes, 5 calves from each group were administered a therapeutic dose (10 mg/kg of body weight) of morantel tartrate. All calves were necropsied 1 week later, and the abomasal and small intestinal nematodes were isolated, identified, and enumerated. A comparison of efficacies between nonmedicated and morantel tartrate-treated calves of each pasture demonstrated that morantel was equally effective against the gastrointestinal nematode infections, regardless of infection source (ie, pasture A vs pasture B). The overall nematode reductions due to morantel tartrate treatment of calves that grazed pastures A and B were 98% and 96%, respectively. It was concluded that the sensitivity of gastrointestinal nematodes to morantel tartrate was not diminished in calves maintained on pasture B, which had been stocked with morantel sustained-release bolus-treated calves for the preceding 2 grazing seasons.     

Autumn acquisition of nematodes by calves given a morantel sustained-release bolus the preceding spring

Reinfection with nematodes late in the grazing season was assessed in calves treated the preceding spring with a morantel sustained-release bolus (MSRB). During an initial 155-day grazing period, MSRB-treated calves (n = 15) grazed a pasture used the preceding year for identically treated calves (MSRB pasture). Control calves (n = 15) were not given anthelmintic treatment in the spring and grazed heavily contaminated herbage for the initial 155-day period (control pasture). At the end of the initial grazing period, 3 calves from each group were killed for parasite recovery and counting, with control calves found to harbor 9.2 times more nematodes, compared with the MSRB-treated calves. Nematode counts from tracers killed periodically during the initial grazing period were of similar proportions, reflecting the much greater nematode exposure experienced by the control calves, compared with the MSRB-treated calves. At the end of the initial grazing period, 10 calves (5/group) were placed on a common, contaminated pasture after all were treated twice with fenbendazole (10 mg/kg of body weight, 7 days apart) while on concrete. The second grazing period was for 29 days, followed by a 3-day confinement on concrete. Then, the calves were killed and necropsied. During the 29-day grazing period, the MSRB-treated calves maintained their weight advantage over the control calves, and significant differences in nematode egg counts were not found between the 2 groups of calves. At necropsy, the MSRB-treated calves harbored 27.9% fewer nematodes than did the controls, indicating that prior therapeutic and prophylactic anthelmintic activities of the MSRB did not predispose the animals to enhanced acquisition of nematodes after MSRB protection.     

Sub-clinical parasitism in spring-born, beef suckler calves: epidemiology and impact on growth performance during the first grazing season

Sub-clinical parasitism in spring-born single suckled beef calves was investigated from the middle of their first grazing season until weaning or housing later the same year. The study was conducted on four beef suckler herds in southern England over a 3-year period and involved a total of 334 spring-born beef suckler calves and their dams. The animals were grazed extensively on pastures naturally infected with nematode larvae. At the start of each period of observation, faecal samples were taken from calves and cows and subjected to routine worm egg counts; calves were re-sampled at the end of the grazing season.In July in each year and at each location the calves were ranked by initial weight within sex, paired according to rank and randomly allocated to either an untreated control group or a group in which the calves were each treated with an ivermectin sustained-release (SR) bolus. The calves in both trial groups, and their dams, were grazed together until weaning or housing. The calves were weighed at the initial allocation and at the end of the study. The adult cows were not treated with any anthelmintic during the study.The faecal nematode egg counts (FECs) conducted in July showed that the suckler cows were excreting worm eggs at low concentrations: range 0-100 eggs per gram (epg), with one individual count of 500epg, 88% of the cows sampled had counts of <50epg. Similarly, the counts from the calf samples were fairly low in July: range 0-250epg, 73% of the calves sampled had counts of <50epg. By the end of the grazing season, the faecal samples from the untreated control calves showed higher values: range 0-650epg, with only 58% having an epg of <50.The average rate of daily liveweight gain in the untreated heifer calves was 0.79kg per day, the corresponding figure for the heifer calves treated with the ivermectin SR bolus in mid-summer was 0.88kg per day; the difference of 90g per day was significantly different (P=0.0118). The average rate of daily liveweight gain in the untreated bull calves was 0.91kg per day, the corresponding figure for the bull calves treated with the ivermectin SR bolus in mid-summer was 1.01kg per day; the difference was significantly different (P=0.0169).     

Immunity of ivermectin treated cattle to challenge from helminth parasites in the following season

Two groups of yearling cattle which had been treated with ivermectin either three and eight, or three, eight and 13 weeks after turn out to trichostrongyle contaminated pasture in their first grazing season were exposed in the following season to natural challenge with helminth parasites. To assess their immunity to this challenge each group shared a pasture with parasite naive first season calves. No anthelmintic treatments were administered at any time during the year. Throughout the grazing period the yearlings showed normal respiratory rates, negative faecal lungworm larval counts, and, relative to the calves, low faecal trichostrongyle egg counts. All the first season calves developed patent lungworm infections and on one occasion the mean respiratory rates of each group of calves were significantly greater than those of the yearling cattle. At the end of the grazing period, from early May until late September or October 1986, the cattle were removed from pasture and together with parasite naive controls challenged with either 10 or 22 third stage larvae of Dictyocaulus viviparus/kg bodyweight and necropsied between 18 and 23 days later. Although the experimental challenge resulted in relatively heavy lungworm infection of the naive controls, none of the yearlings and only three of the 11 calves which had been at pasture were found to be infected. However, large numbers of arrested fourth stage larvae of Ostertagia ostertagi were present in all the naturally infected yearlings and calves.     

Efficacy of low doses of fenbendazole and its administration via drinking water in the prophylaxis of nematodiasis in grazing calves

Under experimental conditions, fenbendazole given at doses of 0.4 and 1.0 mg/kg body weight suppressed calves' faecal output of Ostertagia and Cooperia species eggs and Dictyocaulus viviparus larvae. Both dose levels were given in the form of small daily drenches and the higher level showed greater efficacy. In a grazing experiment, medication with fenbendazole at 1.0 mg/kg/day administered intermittently to calves using an automatic dose dispenser almost completely suppressed the output of trichostrongylid eggs. As a result, infection on the pasture and in the calves remained at a low level throughout the grazing season. By contrast, control pasture and control calves showed rather heavy infection from mid-August onwards with significantly lower weight gains and widespread signs of parasitic gastroenteritis. At post mortem examination of representative calves from each group in November, the medicated animals had 99 per cent less Ostertagia species, whether adults or larvae arrested at the early fourth stage, and 95 per cent less Cooperia species compared with controls. Medication in the drinking water suppressed the faecal output of D viviparus larvae for most of the grazing season by comparison with the controls but the medicated calves became infected with this parasite towards the end of the season. Until this problem is overcome, precautions against parasitic bronchitis are advised when this system of medication is adopted.     

A field study of the ivermectin sustained-release bolus in the seasonal control of gastrointestinal nematode parasitism in first season grazing calves

The effect of an ivermectin sustained-release bolus (I-SRB) on the epidemiology of nematode parasites and on calf productivity was evaluated in a field trial under Northwestern European conditions. Twenty parasite-naive female Friesian calves (principals) aged 5–9 months were used together with six male Friesian tracer calves. Principal calves were allocated by restricted randomization on day 0 body weight to either an untreated control group or a group given one I-SRB, designed to deliver 12 mg ivermectin per day for 135 days, orally on day 0. Each group was grazed on adjacent paddocks, naturally contaminated with parasitic nematode larvae, from 13 May 1991 (day 0) until housing on 30 September (day 140). Body weights of principal calves were recorded and individual blood and faecal samples taken at regular intervals throughout the trial. Pasture nematode contamination was monitored by larval counts on herbage and by worm counts of tracer calves grazed on each paddock from day 126 to day 140. Nematode contamination levels on the control paddock did not rise until the end of the grazing season, as a result of a mid-summer drought period. The period of exposure to a high larval challenge was too short to provoke body weight losses and clinical parasitic gastroenteritis in control calves. Use of the I-SRB resulted in zero faecal egg counts of trichostrongyles during the whole pasture season, thereby preventing a build-up of parasitic gastrointestinal nematodes on pasture. During the second grazing season no signs of parasitic gastroenteritis were detected in any animal, but an outbreak of parasitic bronchitis (PB) was observed in both experimental groups, indicating that PB can occur in older cattle regardless of the control measures taken to prevent clinical parasitism during the first grazing season.